Source: Citybizlist

Johnson & Johnson: Johnson & Johnson Acquires Intra-Cellular Therapies

NEW BRUNSWICK, N.J.-(BUSINESS WIRE)-Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular... Read MoreThe post Johnson & Johnson Acquires Intra-Cellular Therapies appeared first on citybiz.

Read full article »

Johnson & Johnson's Competitors | Johnson & Johnson's News | Johnson & Johnson's Financials

Followers on Owler

38,928

Annual Revenue

$50-100B

Employees

100K-9.9M

Chairman & CEO

Joaquin Duato

CEO Approval Rating

62/100

Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices.